Delivery Order SPE2DB22D3501-SPE2DB24FXB70

Award Date 9/24/24
Potential Completion Date 9/25/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,563.65, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a type of insulin medication. The contract has an ultimate completion date of January 17, 2025 and is a firm fixed-price contract. There is no set-aside designation mentioned in the information provided. AmerisourceBergen Drug Corp...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,023.83 contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML pharmaceuticals. The order has an ultimate completion date of August 15, 2024 and utilizes a Firm Fixed Price pricing type. Amerisourcebergen, a major pharmaceutical distributor, holds a DLA Troop Support Medical IDC valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,139.39 firm-fixed-price contract is to deliver NOVOLOG 100 UNIT/ML VIAL 10ML, a type of insulin medication. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for 4,565,231,022 units of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The fixed-price contract has a total ceiling value of $2,394.28 and a completion date of July 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to supply the DLA with essential medical commodities,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $2,833.59 fixed-price contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML pharmaceutical products. The order has a completion date of July 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous indefinite delivery contracts (IDCs) by the DLA and other federal agencies to supply a wide range of medical...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The $2,454.00 firm-fixed-price award is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,056.62, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a diabetes medication. The contract has a firm fixed price pricing type and an ultimate completion date of March 31, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,371.87, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract has an ultimate completion date of November 15, 2024. Amerisourcebergen, a for-profit corporate entity registered in the System for Award Management (SAM.gov), holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,261.55 firm fixed-price contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract has an ultimate completion date of February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.49 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract has an ultimate completion date of April 20, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FXB70
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,454.00 firm-fixed-price contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a type of insulin medication. The order has a completion date of September 25, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies to provide a wide range of medical commodities, including prescription drugs, medical supplies, and equipment. These IDCs, valued up to $999,999,999 and $750,000, enable efficient procurement of essential healthcare products to support military treatment facilities, veterans' hospitals, and other government healthcare programs nationwide. This contract award is not designated as a set-aside.

Generated 12/24/24, 9:38 AM